TRINITY BIOTECH PLC (TRIB) Form 6-K — Jul 22, 2026
Trinity Biotech plc announced a 1-for-30 reverse split of its American Depositary Shares (ADSs), changing the ratio from one ADS representing 20 Class A ordinary shares to one ADS representing 600 Class A ordinary shares. The ratio change is effective as of the open of trading on July 24, 2026, and is intended to help the company regain compliance with the Nasdaq $1.00 minimum bid price requirement.
Key figures
- New ads ratio
- 1:600
- Old ads ratio
- 1:20
- Effective date
- July 24, 2026
- Reverse split factor
- 1-for-30
- Nasdaq minimum bid price
- $1.00
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.